Location of Repository

Designing the selenium and bladder cancer trial (SELEBLAT), a phase lll randomized chemoprevention study with selenium on recurrence of bladder cancer in Belgium

By Maria E Goossens, Frank Buntinx, Steven Joniau, Koen Ackaert, Filip Ameye, Ignace Billiet, Johan Braeckman, Alex Breugelmans, Jochen Darras, Kurt Dilen, Lieven Goeman, Eliane Kellen, Bertrand Tombal, Siska Van Bruwaene, Ben Van Cleyenbreuge, Frank Van der Aa, Kris Vekemans, Hendrik Van Poppel and Maurice P Zeegers
Topics: Study Protocol
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:3352119
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Preview

    Citations

    1. (1992). Barton BA: 13-cis-retinoic acid in chemoprevention of superficial bladder cancer.
    2. (2007). Buntinx F: Occurrence of both bladder and prostate cancer in five cancer registries in Belgium, The Netherlands and the United Kingdom.
    3. (2006). Chemopreventive trials in urologic cancer. Rev Urol
    4. (2009). Cheng KK: The West Midlands Bladder Cancer Prognosis Programme: rationale and design.
    5. (1977). Comparisons of placebo, pyridoxine, and topical thiotepa in preventing recurrence of stage I bladder cancer. Urology
    6. (1995). F: Adjuvant treatment with a vitamin A analogue (etretinate) after transurethral resection of superficial bladder tumors. Final analysis of a prospective, randomized multicenter trial in Switzerland. Eur Urol
    7. (2010). FR: No effect of selenium supplementation on serum glucose levels in men with prostate cancer.
    8. (2003). FR: Selenium and inhibition of disease progression in men diagnosed with prostate carcinoma: study design and baseline characteristics of the ‘Watchful Waiting’ Study. Anticancer Drugs
    9. (2010). Guallar E: Selenium status and cardiometabolic health: state of the evidence. Nutr Metab Cardiovasc Dis
    10. (2009). Guallar E: Serum selenium concentrations and diabetes in U.S. adults: National Health and Nutrition Examination Survey (NHANES) 2003-2004. Environ Health Perspect
    11. (2009). Guallar E: Serum selenium concentrations and hypertension in the US Population. Circ Cardiovasc Qual Outcomes
    12. (2010). Huang KC: Serum selenium concentration is associated with metabolic factors in the elderly: a cross-sectional study. Nutr Metab (Lond)
    13. (2000). Intakes for Vitamin C, Vitamin E, Selenium and Carotenoids.
    14. (2008). Kinukawa N: Prevention of recurrence with epirubicin and lactobacillus casei after transurethral resection of bladder cancer.
    15. (1994). Megadose vitamins in bladder cancer: a double-blind clinical trial.
    16. (2011). MR: Diabetes and risk of bladder cancer: evidence from a case-control study in New England. Cancer
    17. (2008). Pisters LL, et al: Phase III prevention trial of fenretinide in patients with resected non-muscle-invasive bladder cancer. Clin Cancer Res
    18. (2007). Reid ME: Effects of long-term selenium supplementation on the incidence of type 2 diabetes: a randomized trial. Ann Intern Med
    19. (2006). Reid ME: Effects of selenium supplementation on cardiovascular disease incidence and mortality: secondary analyses in a randomized clinical trial.
    20. (1995). S: Preventive effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer in a double-blind trial. The BLP Study Group. Eur Urol
    21. (2009). Selenoproteins and human health: insights from epidemiological data. Biochim Biophys Acta
    22. (2009). Stasi SM, Witjes JA: An individual patient data meta-analysis of the long-term outcome of randomised studies comparing intravesical mitomycin C versus bacillus Calmette-Guerin for non-muscle-invasive bladder cancer. Eur Urol
    23. (2007). Struijker-Boudier HA: Blood pressure and blood selenium: a cross-sectional and longitudinal population study. Eur Heart J
    24. (2006). Wilding G: Randomized prospective phase III trial of difluoromethylornithine vs placebo in preventing recurrence of completely resected low risk superficial bladder cancer.
    25. (1995). YM: Studies on human dietary requirements and safe range of dietary intakes of selenium in China and their application in the prevention of related endemic diseases. Biomed Environ Sci

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.